Immunostimulant therapy using agonistic cytokines or activating antibodies has been associated with off-target side effects, failure to preferentially activate cytotoxic lymphocytes (CTLs) over ...
This article and associated images are based on a poster originally authored by Aida Ashrafzadeh, Marcos Rubio-Alarcón, Graham Ladds, and Taufiq Rahman, and presented at ELRIG Drug Discovery 2025 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback